Ellevest, Inc.

SEC CIK: 0001644128
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

JNCE holding history

Jounce Therapeutics, Inc. in every 13F filed by Ellevest, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JNCE overview All 13F holders of JNCE Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 4; Since Q1 2021

Holdings of JNCE by Ellevest, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−15−100.0%	Sold out	Holders
Q4 2021	15	$0	0.0%	00.0%	Unchanged	Holders
Q3 2021	15	$0	0.0%	−19−55.9%	Reduced	Holders
Q2 2021	34	$0	0.0%	00.0%	Unchanged	Holders
Q1 2021	34	$0	0.0%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.